Literature DB >> 21798897

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.

Nishant Agrawal1, Mitchell J Frederick, Curtis R Pickering, Chetan Bettegowda, Kyle Chang, Ryan J Li, Carole Fakhry, Tong-Xin Xie, Jiexin Zhang, Jing Wang, Nianxiang Zhang, Adel K El-Naggar, Samar A Jasser, John N Weinstein, Lisa Treviño, Jennifer A Drummond, Donna M Muzny, Yuanqing Wu, Laura D Wood, Ralph H Hruban, William H Westra, Wayne M Koch, Joseph A Califano, Richard A Gibbs, David Sidransky, Bert Vogelstein, Victor E Velculescu, Nickolas Papadopoulos, David A Wheeler, Kenneth W Kinzler, Jeffrey N Myers.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. To explore the genetic origins of this cancer, we used whole-exome sequencing and gene copy number analyses to study 32 primary tumors. Tumors from patients with a history of tobacco use had more mutations than did tumors from patients who did not use tobacco, and tumors that were negative for human papillomavirus (HPV) had more mutations than did HPV-positive tumors. Six of the genes that were mutated in multiple tumors were assessed in up to 88 additional HNSCCs. In addition to previously described mutations in TP53, CDKN2A, PIK3CA, and HRAS, we identified mutations in FBXW7 and NOTCH1. Nearly 40% of the 28 mutations identified in NOTCH1 were predicted to truncate the gene product, suggesting that NOTCH1 may function as a tumor suppressor gene rather than an oncogene in this tumor type.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798897      PMCID: PMC3162986          DOI: 10.1126/science.1206923

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  22 in total

1.  Notch1 antiapoptotic activity is abrogated by caspase cleavage in dying T lymphocytes.

Authors:  L Y Cohen; M Bourbonnière; L Sabbagh; A Bouchard; T Chew; P Jeannequin; C Lazure; R-P Sékaly
Journal:  Cell Death Differ       Date:  2005-03       Impact factor: 15.828

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.

Authors:  J R Berenson; J Yang; R A Mickel
Journal:  Oncogene       Date:  1989-09       Impact factor: 9.867

4.  Notch1 functions as a tumor suppressor in mouse skin.

Authors:  Michael Nicolas; Anita Wolfer; Kenneth Raj; J Alain Kummer; Pleasantine Mill; Mascha van Noort; Chi-chung Hui; Hans Clevers; G Paolo Dotto; Freddy Radtke
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

5.  Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.

Authors:  J C Aster; E S Robertson; R P Hasserjian; J R Turner; E Kieff; J Sklar
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

6.  Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.

Authors:  Vera Balz; Kathrin Scheckenbach; Karl Götte; Ulrike Bockmühl; Iver Petersen; Henning Bier
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.

Authors:  Harriet C Hafkamp; Ernst J M Speel; Annick Haesevoets; Fredrik J Bot; Winand N M Dinjens; Frans C S Ramaekers; Anton H N Hopman; Johannes J Manni
Journal:  Int J Cancer       Date:  2003-11-10       Impact factor: 7.396

8.  Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.

Authors:  J A Brennan; J O Boyle; W M Koch; S N Goodman; R H Hruban; Y J Eby; M J Couch; A A Forastiere; D Sidransky
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

9.  TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Authors:  L W Ellisen; J Bird; D C West; A L Soreng; T C Reynolds; S D Smith; J Sklar
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.

Authors:  Apostolos Klinakis; Camille Lobry; Omar Abdel-Wahab; Philmo Oh; Hiroshi Haeno; Silvia Buonamici; Inge van De Walle; Severine Cathelin; Thomas Trimarchi; Elisa Araldi; Cynthia Liu; Sherif Ibrahim; Miroslav Beran; Jiri Zavadil; Argiris Efstratiadis; Tom Taghon; Franziska Michor; Ross L Levine; Iannis Aifantis
Journal:  Nature       Date:  2011-05-12       Impact factor: 49.962

View more
  800 in total

Review 1.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

Review 2.  Exploiting the curative potential of adoptive T-cell therapy for cancer.

Authors:  Christian S Hinrichs; Steven A Rosenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

3.  Pten loss induces autocrine FGF signaling to promote skin tumorigenesis.

Authors:  Kristina Hertzler-Schaefer; Grinu Mathew; Ally-Khan Somani; Sunil Tholpady; Madhavi P Kadakia; Yiping Chen; Dan F Spandau; Xin Zhang
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 4.  EGFR-targeted therapies in the post-genomic era.

Authors:  Mary Jue Xu; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

5.  A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.

Authors:  Julie E Bauman; Hugo Arias-Pulido; Sang-Joon Lee; M Houman Fekrazad; Hiroyuki Ozawa; Elana Fertig; Jason Howard; Justin Bishop; Hao Wang; Garth T Olson; Michael J Spafford; Dennie V Jones; Christine H Chung
Journal:  Oral Oncol       Date:  2013-02-04       Impact factor: 5.337

Review 6.  Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.

Authors:  Shaohua Ma; Chorlada Paiboonrungruan; Tiansheng Yan; Kevin P Williams; M Ben Major; Xiaoxin Luke Chen
Journal:  Ann N Y Acad Sci       Date:  2018-05-11       Impact factor: 5.691

Review 7.  Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma.

Authors:  Paulina Kozakiewicz; Ludmiła Grzybowska-Szatkowska
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

8.  Small GTPase RhoE/Rnd3 is a critical regulator of Notch1 signaling.

Authors:  Zehua Zhu; Kristina Todorova; Kevin K Lee; Jun Wang; Eunjeong Kwon; Ivan Kehayov; Hyung-Gu Kim; Vihren Kolev; G Paolo Dotto; Sam W Lee; Anna Mandinova
Journal:  Cancer Res       Date:  2014-02-13       Impact factor: 12.701

9.  Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy.

Authors:  Rong Zhong; Matt Pytynia; Charles Pelizzari; Michael Spiotto
Journal:  Cancer Res       Date:  2014-02-13       Impact factor: 12.701

10.  A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.

Authors:  Kantima Leelahavanichkul; Panomwat Amornphimoltham; Alfredo A Molinolo; John R Basile; Sittichai Koontongkaew; J Silvio Gutkind
Journal:  Mol Oncol       Date:  2013-10-12       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.